Background/Aims: There is limited knowledge on the gender differences in the effects of dietary fructose. In the current study, we investigated whether long-term fructose intake impacts metabolic parameters and vascular reactivity differently between male and female rats. Moreover, we tested whether resveratrol has a gender-specific effectiveness on the alterations. Methods: Male and female rats were divided into four groups as control; resveratrol; fructose and resveratrol plus fructose. Fructose was given to the rats as 10% solution in drinking water for 24 weeks. All rats were fed with the standard diet with or without resveratrol. Results: High-fructose diet increased plasma insulin, triglyceride and VLDL levels as well as omental weights in both genders. Long-term dietary fructose causes marked increase in body weight of males, but not females. Dietary fructose impaired endothelial relaxation to acetylcholine and intensified contraction to phenylephrine in the aortas of male and female rats, but differently it also reduced insulin-induced vasodilation in aortas of female rats. These changes were associated with decreased expression levels of endothelial nitric oxide synthase (eNOS) mRNA and protein, but increased in inducible NOS (iNOS), in aortas of male and female rats. Dietary fructose suppressed expression levels of sirtuin 1 (SIRT1) and insulin receptor substrate-2 (IRS-2) mRNA in aortas from female rats. Resveratrol supplementation efficiently restored fructoseinduced metabolic and vascular dysfunction in both genders probably by regulating eNOS and iNOS production. Moreover, the augmentations in SIRT1 and IRS-2 mRNA in females and IRS-1 mRNA in males may possibly contribute to the beneficial effects of resveratrol as well. Conclusion: Long-term fructose intake may differently affect metabolic and vascular function between male and female rats, which are modified by resveratrol.
groups as control; resveratrol; fructose and resveratrol plus fructose (resveratrol + fructose). Fructose was given to the rats as 10% solution in drinking water ad libitum for 24 weeks. Resveratrol was mixed with powdered material of standard rodent chow at a dose of 500 mg/kg and then the combination was pressed to make a chow pellet in the production company. The chow was stocked in temperature-controlled (4 o C) and dark rooms. All rats were fed with the standard diet with or without resveratrol ad libitum for 24 weeks. Body weights, food and liquid intakes were recorded weekly during the follow-up period. The daily resveratrol ingestion was calculated from the amount of chow intake. The daily fructose consumption was determined by measuring the liquid intake. At the end of follow-up period, the rats were anesthetized with a mixture of ketamine-xylazine (100 and 10 mg/kg, respectively, i.p.) and thereafter, blood samples were rapidly collected via cardiac puncture. The thoracic aortas and whole omentum were dissected, washed and some part of the tissues were blotted dry and frozen in liquid nitrogen and stored at −85 °C.
Measurement of metabolic parameters in the plasma
Cardiac blood samples of non-fasted rats were immediately centrifuged at +4 °C and 10,000g for 30 min. Samples were stored at −85 °C until analysis. Plasma triglyceride, very low density lipoprotein (VLDL), high density lipoprotein (HDL) and total cholesterol levels were determined by standard enzymatic techniques. Insulin levels were assessed by using ELISA kit (Mercodia) according to the manufacturer's instructions. Glucose levels were measured using a glucometer (Roche Diagnostics) in blood collected from the tail veins of rats.
Measurement of vascular reactivity in the thoracic aorta
The thoracic aortas were isolated and immediately transferred to a cold Krebs solution that contained (mM): NaCl 118, KCl 4.73, KH 2 PO 4 1.2, MgSO 4 .7H 2 O 1.2, CaCl 2 2.5, NaHCO 3 25 , glucose 11 and EDTA 0.026. The aortic rings were suspended between a tissue holder and isometric force-displacement transducer (EMKA, Paris) in a 5 ml organ bath filled with Krebs solution at 37°C and oxygenated by 95% O 2 and 5% CO 2 . Special care was taken to preserve the endothelium during the preparation of the aortic rings. Functional integrity of the endothelium was checked with the application of acetylcholine (10 -6 M) on phenylephrine (10 -6 M)-precontracted aortic rings and preparations demonstrating <70% relaxations in control rats from both genders were discarded [10, 11] . The cumulative concentration-response curves of phenylephrine (10 -9 -10 -4 M) were constructed in the aortic rings. The relaxant effects of acetylcholine (10 -9 to 10 -4 M) and insulin (10 -9 to 3x10 -6 M) were studied in the rings constricted submaximally with phenylephrine (10 -6 M).
Determination of gene expressions of IRS-1, IRS-2, eNOS, iNOS and SIRT-1 with real time polymerase chain reaction
Total RNAs were isolated from arterial tissues using the RNeasy total RNA isolation kit (Qiagen, Venlo, Netherlands) as described according to the manufacturer protocol. After isolation, amount and quality of the total RNA were determined using spectrophotometry at 260/280 nm. 1 µg of total RNA were reverse transcribed to cDNA using commercial first strand cDNA synthesis kit (Thermo Scientific, USA) as described by the supplier. Gene expressions of IRS-1, IRS-2, eNOS, iNOS and SIRT-1 were determined with real time PCR as we described in detail previously [13] . Relative expressions of genes with respect to internal control; glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were calculated with the efficiency corrected advance relative quantification tool provided by the LightCycler® 480 SW 1.5.1 software.
Immunoblot analysis of IRS-1, eNOS and iNOS proteins
Frozen aortic samples were homogenized in two volumes of homogenization medium containing 50 mM Tris, 150 mM NaCl, 5 mM EDTA, 1% (w/w) Triton x-100, 0.26% (w/v) sodium deoxycholate, 50 mM sodium flouride, 0.1 mM sodium ortovanadate and 0.2 mM PMSF by using Tissue Ruptor TM (Qiagen, Venlo, Netherlands) homogenizer and centrifuged at 1500g for 10 min at 4 °C. Total protein concentrations of the resulted supernatants were determined by Lowry method [14] . Equal amounts of protein (75 µg) from different groups were separated by SDS-PAGE and electroblotted onto PVDF membranes. The blotted membranes were blocked with 3% BSA. eNOS (anti-eNOS rabbit IgG, Abcam, 1:1000), iNOS (anti-iNOS rabbit IgG, Abcam, 1:1000) and IRS-1 (anti-IRS1 rabbit IgG, Abcam, 1:1000) antibodies were used for the priming for 2 h with constant shaking. As an internal control, GAPDH proteins were also primed with their primary antibody (anti-GAPDH rabbit IgG, Santa Cruz, 1:2000). Horseradish peroxidase (HRP) conjugated secondary 
Statistical analysis
Data was given as mean ± standard error of the mean (SEM); n is the number of rats. The relaxations to acetylcholine and insulin were expressed as percent decreases of the precontraction induced by phenylephrine. Contractile responses to phenylephrine were calculated as a percentage of the KCl (40 mM)-induced contraction. The concentration-response curves to agonists were compared at each concentration for differences. The maximal response (E max ) and potency (EC 50 ) of the agents were determined by using Prism 5.02 GraphPad software. EC 50 values were given as −log M. Gene and protein expression data was normalized to the mean of the control groups, which was arbitrarily set to 100% and the relative changes were given as percent changes over control. Statistical comparisons were performed using unpaired Student's t test or one-way ANOVA followed by the Bonferroni post hoc test. P values smaller than 0.05 were considered as statistically significant.
Results

Resveratrol intake
Resveratrol consumption of the rats was calculated to be approximately 36 mg/kg body weight/day in males and 40 mg/kg body weight/day in females in the healthy conditions. In fructose-treated groups, resveratrol intake was calculated as 29 mg/kg body weight/day in male and 27 mg/kg body weight/day in female rats.
The effects of dietary fructose and resveratrol on body weight, omental fat weight, caloric intake and metabolic parameters
As shown in Table 1 , the total caloric intakes of fructose-treated male and female rats were higher than those of their matching controls, while unchanged after resveratrol supplementation. Fructose-treated male rats gained significantly higher weight than control group, whereas the body weight of fructose-treated female rats showed a tendency towards an increase compared to controls, but was not found significant. Resveratrol-treated healthy male and female rats consumed more total calories, however gained less weight than their matching controls. Notably, dietary fructose increased omental fat mass in both male and female rats which responded to resveratrol supplementation with a significant reduction (Fig. 1) .
Fig. 1.
The ratio of omental fat weight to body weight from the control, resveratrol (Res), fructose (Fruc) and resveratrol+fructose (Res+Fruc)-treated male and female rats. Values are expressed as mean ± SEM, n = 6-10. * P < 0.05, significantly different from control. # P < 0.05, significantly different from fructosetreated rats.
† P < 0.05, significantly different from male. 
Cellular Physiology and Biochemistry
Furthermore, dietary fructose elevated plasma triglyceride, VLDL and insulin levels in both genders. Resveratrol supplementation significantly attenuated the elevated levels of triglyceride, VLDL and insulin in rats fed with fructose (Table 1) . Dietary fructose did not increase blood glucose levels in both genders but resveratrol supplementation caused a tendency towards reduction. Resveratrol significantly raised HDL levels in female rats. Total cholesterol levels were higher in female than in male rats after the treatments.
The effects of dietary fructose and resveratrol on relaxation response to acetylcholine and insulin in aortic rings
Dietary fructose decreased acetylcholine-induced relaxations, especially in terms of maximal responses (E max ), in aortic rings from both genders when compared to the controls. The relaxations, in terms of EC 50 and E max , were improved after resveratrol supplementation in fructose-treated male and female rats (Figs. 2A and B, Table 2 ); while an endotheliumindependent relaxation response to sodium nitroprusside (10 -10 to 10 -5 M) was found indifferent between the groups (data not shown). Insulin-induced relaxations showed a gender-dependent discrepancy in rat aortic rings, which were more pronounced in those of females. Resveratrol extensively promoted the maximal relaxation to insulin, especially in males. Dietary fructose importantly weakened insulin-induced relaxations in the aortic rings of females. Conversely, resveratrol supplementation enhanced the relaxations to insulin in both male and female rats fed with fructose (Figs. 3A and B, Table 3 ). 
The effects of dietary fructose and resveratrol on contractile response to phenylephrine in aortic rings
Phenylephrine-induced contractions were more pronounced in male than in female rats, in terms of E max . Dietary fructose strengthened the contractions to phenylephrine in aortic rings of male and female rats, while resveratrol intake produced a tendency to reduction in the contractions. On the other hand, resveratrol supplementation in fructose diet-fed rats suppressed the augmented responsiveness to phenylephrine, in terms of E max and EC 50 , especially in males (Figs. 4A and B, Table 4 ).
The effects of dietary fructose and resveratrol on IRS-1, IRS-2, SIRT1, eNOS and iNOS gene and protein expressions
The gene and protein expression levels of IRS-1, eNOS and iNOS expression in the aortic samples from male and female rats were established by real-time PCR and Western Blot analysis, respectively. Accordingly, resveratrol supplementation increased IRS-1 mRNA expression in aortas of male rats from control and fructose-treated groups, whereas in females, it produced an increase in control group, but only a trend towards elevation in fructose-treated group. In contrary, resveratrol supplementation markedly increased IRS-2 mRNA expression in the aortas of female rats obtained from either control or fructosetreated groups, without any significant influence in those values of male rats. Moreover, a reduction on IRS-2 mRNA expression was noted in aortas of female rats fed with fructose when compared to control. However, no change was found in IRS-1 protein levels between the groups from both genders (Figs. 5A1/2 and 6A1/2 and 6B1/2). in aortas from male and female rats fed with fructose, when compared to controls. On the other hand, resveratrol supplementation significantly suppressed the increased expressions of iNOS in aortas from male and female rats fed with fructose (Figs. 5D1/2 and 6A1/2 and 6D1/2). Fructose feeding reduced the expression of SIRT1 mRNA levels in aortas only from female rats fed with fructose which is restored by resveratrol (Figs. 5E1/2 ).
Discussion
In our recent studies, we demonstrated that fructose intake is a potential risk factor in the development of cardiovascular and metabolic disorders, which can be alleviated by resveratrol supplementation, in male rats. However, the gender-different influence of dietary fructose and its modification by resveratrol have not been examined yet. The present study originally evaluated gender-dependent differences on dietary fructose-induced metabolic disturbances and their exerted modulation by resveratrol. Herein, we showed that long-term fructose consumption has gender-different influence on body weights of rats, but not on abdominal fat accumulations. Although, the other metabolic parameters and vascular functions appear to be equally affected from dietary fructose in both genders, there were some gender differences including vasorelaxation to insulin, IRS-2 and SIRT1 expressions. Resveratrol supplementation improves the disturbances related to chronic fructose consumption in both male and female rats, probably by regulating eNOS and iNOS productions. The gender-dependent effects of fructose could be an important topic to argue when considered along with high fructose intake in the current human diet.
In animal studies, it is of interest to note that fructose given in chow to induce a metabolic disturbance is much higher than that is present in a regular solid human diet; besides 50% of total sugar consumption in human is coming from soft drinks [9, 15] . Therefore, in this study, fructose was given to rats in the drinking water as a dilution of 10% for 6 months period to mimic the sugar concentration of regular soft drinks that have 7-13% carbohydrate content [16] and thus provide a right reflection of the dietary pattern in humans.
Previous examinations showed that dietary fructose consumption in rats causes a metabolic disorder associated with hyperinsulinemia, hypertriglyceridemia, vascular and hepatic dysfunction, although the body weights have not been usually increased [9] . Female rats on fructose diet were shown to be protected from hypertension and hyperinsulinemia, despite the elevated levels of triglycerides, differently from male counterparts, whereas the body weight changes have not been implicated [7] . In the current study, we found that female rats gained less weight than male rats with a chronic fructose diet. The reason for unchanged body weights in the females is not clear, since a higher caloric intake was detectable, compared to the control female rats. However, omental fat tissue weights were increased in both genders similarly on high-fructose diet, proposing that the local fat accumulation could be a more accurate parameter to decide the existence of metabolic disorder. Of note, in female rats, relatively slight weight gain induced by fructose diet does not seem to prevent development of metabolic dysfunction as evidenced by the presence of hyperinsulinemia and hypertriglyceridemia. These findings revealed that metabolic changes are more likely linked to abdominal fat accumulation, but independent from the general obesity. In addition, the control females appeared to have more omental fat mass than males, signifying the gender characteristics. In our previous studies, the weight gaining has not been established in male rats consumed 10% HFCS in drinking water for 10-12 weeks [10, 11] . The discrepancy between these former and the present studies can be explained by the differences in experimental protocol design, in particular with feeding durations to induce metabolic disorder as well as the mixture of HFCS that contains 56% fructose and 37% glucose. Previously, in a high-fat diet-induced obesity model, the male mice were shown to gain more body weight and had severe insulin resistance and adipocyte hypertrophy than those of the females [3, 17] . In these studies, the protection with females to metabolic
abnormalities could be reasonably affirmed to female hormone, estrogen. Overall, the type of diet may differently affect metabolic parameters between males and females. eNOS plays a pivotal role in the modulation of vascular tone and its down-regulation implicates several vasculopathies including metabolic syndrome and diabetes [18] . The effects of insulin are mediated by the binding to insulin receptors / IRS-1, IRS-2, which triggered downstream signaling pathways. Further studies confirmed the existence of a functional connection between insulin signaling and eNOS or SIRT1 [19, 20] . In this study, we showed that dietary fructose reduced relaxations to acetylcholine, but intensified contractions to phenylephrine, in aortas of male and female rats, probably due to low production of nitric oxide, as evidenced by decreased eNOS mRNA and protein expressions. These results are partially in line with the findings of short-term fructose application (10% in drinking water for five weeks) in male rats which decreased the expression levels of IRS-1 and eNOS proteins in the aorta [21, 22] . Herein, fructose diet did not change IRS-1 expression in aortas from both genders, but, decreased IRS-2 mRNA expression only in those of female rats. Parallely, fructose diet diminished insulin-induced vasodilation in the aortas of female rats, which was already more apparent than those of males, signifying the gender characteristics. Suppressed SIRT1 expression by fructose could also play a role in the diminished relaxation of the females, as described in our previous study [10] . Previously, the lack of IRS-2 has been determined to cause dyslipidemia, hypertension and insulin resistance in mice [23] . Our recent studies showed that dietary HFCS (10% in drinking water) consumption did not decrease insulin-induced relaxation and IRS-1/2 mRNA expressions in male rats. However, a blunted endothelial relaxation to acetylcholine and intensified contractions to both endothelin-1 and to angiotensin were determined in male rats on HFCS diet [10, 11] . These results suggested that the relaxation response to insulin shows a specific permanence against sugar rich diets regarding to other endogenous factors in the males. On the other hand, an increased vascular inflammation as evidenced by the induction of iNOS expression, likewise in our previous study [11] , may also contribute to the deteriorated vascular and endothelial function, i.e. response to phenylephrine and acetylcholine, both in male and female rats. Previously, the induction of iNOS was proposed to contribute to the endothelial dysfunction in streptozotocin-induced diabetic rats [24] . It has been suggested that inflammatory mediators may possibly constitute a link between metabolic irregularity and vascular insulin resistance [25] . Moreover, high-fat diet feeding was shown to cause early onset of the inflammation process particularly in the vasculature than the other tissues such as skeletal muscle and liver, indicating a higher sensitivity of vascular systems to harmful effects of nutritional factors [26] . Collectively, suppressed eNOS and provoked iNOS expressions could be an underlying mechanism that influences endothelial and vascular dysfunction initiated by high-fructose diet both in male and female genders.
Resveratrol-supplemented healthy male and female rats consumed more total calories, but gained less weights than the control rats, which may be attributed to its caloric restriction mimetic effect as determined in others and ours previous studies [11, 27, 28] . Supportingly, we found that resveratrol supplementation, in both male and female rats that fed with fructose diet, decreased the body weight gain, similar to mice that fed with a high-fat diet. Furthermore, resveratrol leads to a significant decrease in omental weight in association with the improvement of hyperinsulinemia and hypertriglyceridemia, which shows its favorable effects on metabolic functions. Moreover, enhancement in HDL levels by resveratrol in female rats may be ascribed to its gender specific effect.
Resveratrol was previously shown to contribute to the improvement of insulin resistance, probably via SIRT1-dependent mechanisms, in male mice on a high-fat diet and in other conditions in vitro [28] [29] [30] [31] . Our recent study demonstrated that resveratrol increases vascular insulin sensitivity possibly by promoting eNOS, whereas suppressing iNOS expression, in male rats fed with HFCS [11] . In concert with these findings, augmentation in the expression of eNOS and SIRT1 proteins with resveratrol was associated with the amelioration of endothelial and vascular functions in HFCS-drinking male rats [10] .
Herein, resveratrol improved the vascular responses to acetylcholine and insulin, as well as phenylephrine, in aortas from fructose-fed male and female rats possibly due to increased eNOS, while decreased iNOS expression. In relation to the interaction between insulin signaling pathway and resveratrol, it was shown that resveratrol did not affect expression levels of IRS-1 and IRS-2 [32] , consistent with our previous results in the vasculature of male rats [11] . However, resveratrol reduced IRS-1/2 serine/threonine phosphorylations, which are the feedback inhibitors of insulin signaling pathway, and thus promoted the insulin sensitivity [33] . Resveratrol was also shown to restore hepatic IRS1-mediated signaling and increase insulin sensitivity in IRS2-deficient mice [34] . Moreover, we recently reported that resveratrol enhances the expression levels of IRS-1 and IRS-2 in livers of male rats fed with HFCS, thereby exerting alleviation on hepatic dysfunction [13] . In the current study, long-term resveratrol treatment (for six month) demonstrates a differential impact on the expression levels of IRS1 and IRS2 mRNA, as well SIRT1, between males and females which could have an efficient and distinctive role in its favorable effects. These findings indicate that resveratrol communicates with insulin signaling and its downstream pathways, as represented here via eNOS and SIRT1. Besides, on the basis above findings, it is reasonable to assume that the action of resveratrol on insulin signaling may display some sort of difference depending on metabolic status and gender as well as cell and tissue types. In conclusion, the principal mechanism to improve the effects of resveratrol may involve the regulation of eNOS and iNOS expressions, as the dietary fructose had reciprocally affected these molecules.
In summary, our results demonstrate that, long-term fructose intake may affect metabolic and vascular function between male and female rats differently. Fructose-induced metabolic disorders are more likely related to abdominal fat accumulation, but independent from the general obesity, in females. Resveratrol supplementation has potential to alleviate the disturbances in both genders. The differences observed between male and female rats in response to dietary fructose and their modification by resveratrol can be attributed to the existing different levels of sex hormones in both genders using a speculative approach. To understand the clinical implication of the current findings, more investigations need to be performed on male and female human subjects.
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